Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Ventral intermediate nucleus of the thalamus (Vim) is a specific anatomical region within the motor thalamus that functions as a key relay node in the cerebello-thalamo-cortical pathway (StatPearls, 2023). It receives dense excitatory projections from the contralateral cerebellar dentate nucleus and sends efferents primarily to the primary motor cortex (PubMed PMID: 30251571). While not a molecular target such as a receptor or enzyme, the Vim is a well-established therapeutic target for neurosurgical interventions, including Deep Brain Stimulation (DBS) and Magnetic Resonance-guided Focused Ultrasound (MRgFUS) (NIH, 2022). These procedures are primarily indicated for the management of medication-refractory essential tremor and tremor-dominant Parkinson's disease (Wikipedia, 2024). By delivering high-frequency electrical pulses or creating a focal thermal lesion, clinicians can effectively disrupt the pathological rhythmic oscillations within the circuit that manifest as tremor (PubMed PMID: 29733566). This anatomical targeting allows for precise symptomatic relief in patients who do not respond to systemic pharmacological therapies.
The Vim is targeted via high-frequency electrical stimulation (Deep Brain Stimulation) or thermal ablation (Thalamotomy) to modulate the cerebello-thalamo-cortical circuit and suppress pathological tremor oscillations (StatPearls, 2023; PubMed PMID: 29733566).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ventral intermediate nucleus of the thalamus (Vim).